FRI0463 Secukinumab Improves Minimal Disease Activity Response Rates in Patients with Active Psoriatic Arthritis: Data from The Randomized Phase 3 Study, Future 2
Coates, L.C., Mease, P., Kirkham, B., McLeod, L.D., Mpofu, S., Karyekar, C., Gandhi, K.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.3949
Date:
June, 2016
File:
PDF, 144 KB
english, 2016